These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12643159)

  • 1. The relationship between glucose control and the development and progression of diabetic nephropathy.
    Phillips CA; Molitch ME
    Curr Diab Rep; 2002 Dec; 2(6):523-9. PubMed ID: 12643159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
    Molitch ME
    Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
    Kidney Int; 1995 Jun; 47(6):1703-20. PubMed ID: 7643540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
    Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
    Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
    Mogensen CE; Christensen CK; Vittinghus E
    Diabetes; 1983 May; 32 Suppl 2():64-78. PubMed ID: 6400670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of renal injury in NIDDM patients with microalbuminuria.
    Fioretto P; Mauer M; Brocco E; Velussi M; Frigato F; Muollo B; Sambataro M; Abaterusso C; Baggio B; Crepaldi G; Nosadini R
    Diabetologia; 1996 Dec; 39(12):1569-76. PubMed ID: 8960844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.
    Steinke JM; Sinaiko AR; Kramer MS; Suissa S; Chavers BM; Mauer M;
    Diabetes; 2005 Jul; 54(7):2164-71. PubMed ID: 15983218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients.
    Silveiro SP; Friedman R; de Azevedo MJ; Canani LH; Gross JL
    Diabetes Care; 1996 Feb; 19(2):171-4. PubMed ID: 8718441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term glycemic control and the rate of progression of early diabetic kidney disease.
    Gilbert RE; Tsalamandris C; Bach LA; Panagiotopoulos S; O'Brien RC; Allen TJ; Goodall I; Young V; Seeman E; Murray RM
    Kidney Int; 1993 Oct; 44(4):855-9. PubMed ID: 8258961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.